多变种蛋白质组范围的关联研究,以确定阿尔茨海默病的因果蛋白
Lei Fang1, Haoran Xue2, Zhaotong Lin3
1Division of Biostatistics and Health Data Science, University of Minnesota, Minneapolis, MN, USA.
American journal of human genetics
|January 10, 2025
概括
这项研究使用先进的遗传分析确定了与阿尔茨海默病 (AD) 相关的因果性血蛋白. 这些发现为促进AD病因的分子途径提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 蛋白质组学是指蛋白质组学.
背景情况:
- 阿尔茨海默病 (AD) 是导致痴呆的主要原因,其复杂的病因尚未完全理解.
- 识别AD的因果因素对于开发有效的诊断和治疗方法至关重要.
研究的目的:
- 为了确定与阿尔茨海默病 (AD) 相关的因果性血蛋白.
- 阐明AD的潜在分子路径和遗传基础.
- 改进大规模遗传和蛋白质组研究中的因果推理方法.
主要方法:
- 利用大规模的血蛋白质组数据 (英国生物银行制药蛋白质组项目) 和AD全基因组关联研究 (GWAS) 数据 (国际阿尔茨海默氏症基因组学项目).
- 采用强大的单变量仪表变量 (IV) 回归,使用cis-和trans-protein定量特征位点 (pQTLs).
- 开发并应用了一种新型的多变量IV回归方法 (MV-2ScML) 来区分直接和混效应,对无效IV强大,适用于GWAS总结数据.
主要成果:
- 通过强大的统计分析,确定了与阿尔茨海默病 (AD) 有关的特定因果性血蛋白.
- 证明了cis-和trans-pQTLs在AD因果蛋白鉴定中的实用性.
- 强调了多变量分析对于精细绘制因果蛋白和区分直接和间接影响的重要性.
结论:
- 这项研究确定了可能对阿尔茨海默病 (AD) 发展产生因果影响的关键血蛋白.
- 这项研究提供了关于血蛋白质组途径在AD病因学中的作用的新见解.
- 开发的MV-2ScML方法提供了一种可靠的方法,用于使用遗传和蛋白质组数据在复杂疾病中进行因果推断.
更多相关视频
相关概念视频
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Proteomics
7.2K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.2K
Alzheimer's Disease: Overview
444
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
444


